Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Funding will support research on conditions including fatty liver disease, liver cancer, asthma and chronic kidney disease.
About 63% of American adults consume at least one or more sugar-sweetened beverages daily.
In a mice study, daily consumption of pecans helped reduce inflammation and increase energy expenditure.
For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.
Advanced fatty liver disease led to a greater need for medical care and more difficulty with daily activities.
In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.
Men, people with obesity and people who smoke are more likely to develop NAFLD.
Lean people had a higher mortality rate despite experiencing fewer metabolic problems.
Obesity-linked liver disease has increased 131% in the past three decades.
Restoration of gut function and microbial diversity could lead to improvement of hepatic encephalopathy.
The findings could potentially lead to the first FDA approval of a treatment for fatty liver disease.
While hepatitis C remains a leading cause, cirrhosis is increasingly caused by fatty liver disease and alcohol use.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.